Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Completed
Conditions studied: Infection, E Coli Infections, Klebsiella Infections, Proteus Infections
In brief
The purpose of this study is to review patients with E. coli infections at the University of Pittsburgh Medical Center (UPMC) from September 1, 2006 to August 31, 2007 to determine if these infections have arisen in the community rather than in hospitals or nursing homes. The occurrence of such resistant isolates could be devastating if they were associated with bloodstream infection, such as sometimes accompanies a urinary tract infection, since antibiotic resistant E. coli is not suspected in isolates coming from the community. Therefore, the aims of this study are to: 1. Review whether extended-spectrum beta-lactamase (ESBL)-producing organisms (E. coli, Klebsiella species and Proteus species) are hospital-acquired, healthcare-associated, or community-associated. 2. Investigate the prevalence of ESBL-positive E. coli in foodstuffs (beef, poultry, turkey, and pork), as a potential source for ESBL producers in the community. 3. Compare the clonal relationship of the genome and resistance plasmids carried by the ESBL-producing isolates (healthcare-associated, community-associated, and of animal origin) and study the associations of ESBL-mediated resistance with resistance to other classes of antimicrobials.
Key facts
- Study ID
- NCT00363220
- Run by
- University of Pittsburgh
- People needed
- 100
- Starts
- 2006-08-01
- Expected to finish
- 2015-12-01
- Last updated by the study team
- 2015-12-17
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients with E. coli, Klebsiella species, and Proteus species infections during the time period of the study will be reviewed. A community-associated E. coli isolate will be defined as one which was recovered from a clinical culture from a patient at UPMC who had no established risk factors for infection with an antibiotic resistant organism. Established risk factors are defined as:
- Isolation of the organism two or more days after admission for hospitalization OR
- History of hospitalization, surgery, dialysis, or residence in a long-term care facility within one year before the culture date OR
- The presence of an indwelling catheter or percutaneous medical device (eg, tracheostomy tube, gastrostomy tube, or Foley catheter) at the time of the culture OR
- Previous isolation of an antibiotic resistant organism.
You may not qualify if…
- None
Where it is running
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.